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Chronic ethanol consumption causes structural and functional reorganization in the
hippocampus and induces alterations in the gene expression of gamma-aminobutyric
acid type A receptors (GABAARs). Distinct forced intermittent exposure models
have been used previously to investigate changes in GABAAR expression, with
contrasting results. Here, we used repeated cycles of a Chronic Intermittent Ethanol
paradigm to examine the relationship between voluntary, dependence-associated
ethanol consumption, and GABAAR gene expression in mouse hippocampus. Adult
male C57BL/6J mice were exposed to four 16-h ethanol vapor (or air) cycles in
inhalation chambers alternated with limited-access two-bottle choice between ethanol
(15%) and water consumption. The mice exposed to ethanol vapor showed significant
increases in ethanol consumption compared to their air-matched controls. GABAAR
alpha4 and delta subunit gene expression were measured by qRT-PCR at different
stages. There were significant changes in GABAAR delta subunit transcript levels at
different time points in ethanol-vapor exposed mice, while the alpha4 subunit levels
remained unchanged. Correlated concurrent blood ethanol concentrations suggested
that GABAAR delta subunit mRNA levels fluctuate depending on ethanol intoxication,
dependence, and withdrawal state. Using a vapor-based Chronic Intermittent Ethanol
procedure with combined two-bottle choice consumption, we corroborated previous
evidences showing that discontinuous ethanol exposure affects GABAAR delta subunit
expression but we did not observe changes in alpha4 subunit. These findings indicate
that hippocampal GABAAR delta subunit expression changes transiently over the course
of a Chronic Intermittent Ethanol paradigm associated with voluntary intake, in response
to ethanol-mediated disturbance of GABAergic neurotransmission.
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INTRODUCTION
Prolonged excessive ethanol (EtOH) consumption can lead to increased risk of dependence.
Critical neurobiological changes have been suggested to contribute to the transition from
EtOH consumption and abuse to dependence, leading to behavioral abnormalities, which
ultimately promote and sustain high levels of compulsive drinking (Vengeliene et al., 2009;
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Heilig et al., 2010; Koob and Volkow, 2010; Gorini
et al., 2014; Krishnan et al., 2014). Moreover, EtOH self-
administration behavior can be influenced by perturbations
of the neuroendocrine pathways related to reward, stress, and
anxiety (Koob, 2003).
The hippocampus, important for cognitive function, stress,
and emotional regulation (Bannerman et al., 2014), has
been associated with seeking of and reward from EtOH
(Koob and Volkow, 2010), with evidence of structural and
functional reorganization following chronic EtOH exposure.
Multiple neurotransmitter systems are aﬀected during the
development of EtOH dependence, including the GABAergic
system. A considerable body of evidence suggests that GABAARs
mediate a few of the acute and chronic actions of EtOH
(Faingold et al., 1998; Ueno et al., 2001; Harris et al., 2008;
Trudell et al., 2014), and neuroactive steroids have been
shown to be implicated in these actions (Morrow et al.,
2001), even in isolated hippocampal slices (Sanna et al.,
2004). Given that EtOH can target GABAARs and modulate
their function, the subunit compositions of receptor subtypes
play a crucial role in responses to neurobiological eﬀects
of EtOH in specific brain areas, neuronal populations, and
synaptic localizations. GABAAR gene expression is influenced
by physiological processes, environmental stimuli, and drugs
(Fénelon and Herbison, 1996; Holt et al., 1996; Concas et al.,
1998; Smith et al., 1998b; Sanna et al., 2003; Follesa et al., 2004;
Biggio et al., 2009; Whissell et al., 2015), and chronic EtOH
exposure and withdrawal induce a shift in excitatory/inhibitory
tone, with decreased GABAergic inhibition (Kumar et al., 2009).
Distinct GABAAR subtypes participate in the phasic and tonic
inhibitory control of neuronal activity, and those associated with
phasic inhibition are located at the synapses and are modulated
by higher EtOH doses. In contrast, the subtypes configured with
α4/α6 and δ subunits are located exclusively at extrasynaptic
sites, where their continuous activation elicits tonic GABAergic
inhibition (Farrant and Nusser, 2005; Glykys et al., 2008; Brickley
and Mody, 2012). Such extrasynaptic GABAAR subtypes (and
thus α4 and δ subunits) are expressed preferentially in the
dentate gyrus of the hippocampus, thalamus, and cerebellar
granule cells (Semyanov et al., 2004), with lower levels in the
cortex, striatum, CA1 region, and other brain areas (Pirker et al.,
2000). Their distinctive properties include a higher aﬃnity for
GABA (Saxena and Macdonald, 1996; Brown et al., 2002), higher
sensitivity to neuroactive steroids (Adkins et al., 2001; Brown
et al., 2002; Wohlfarth et al., 2002; Mody, 2008; Sarkar et al.,
2011), and controversially, to acute EtOH (Sundstrom-Poromaa
et al., 2002; Wallner et al., 2003) when compared to other
GABAAR subtypes.
The involvement of the hippocampal GABAergic system
in alcoholism has been emphasized by comparing diﬀerential
GABAergic gene expression within the hippocampus of
alcoholics and in a rat model of vulnerability to EtOH
dependence (Enoch et al., 2012), with congruent findings.
Furthermore, several studies have shown that hippocampal α4
and δ subunit levels are aﬀected by excessive EtOH consumption
and subsequent withdrawal. In rat hippocampus, α4 peptide
levels were upregulated in a region- and time-dependent manner
24 h after a voluntary 40-day EtOH-based liquid diet (Matthews
et al., 1998). Similarly, a 48-h withdrawal period after protracted
(60 days) forced EtOH consumption led to a significant increase
in α4 subunit mRNA levels in the dentate gyrus, CA3, and
CA1 regions (Mahmoudi et al., 1997), accompanied by a
general increase in α4 and γ2 peptide levels and decreases in
α1 and δ peptide levels (Cagetti et al., 2003). Moreover, there
has been evidence of significant increases in the α1, α4, α5,
β1, and γ1 subunit mRNAs in the post-mortem hippocampal
dentate gyrus region of individuals suﬀering from long-term
alcohol dependence (≥80 g alcohol per day; Jin et al., 2012).
Notably, hippocampal overexpression of the α4 subunit has been
associated with increased anxiety (Smith et al., 1998a), which
is thought to contribute to increased vulnerability to EtOH
abuse. All these changes might alter the GABAergic tone and
induce a state of hyperexcitability (Kumar et al., 2009; Olsen and
Spigelman, 2012).
However, other studies have indicated dissimilar results in
both rodent and human hippocampi. Diverse forced intermittent
exposure paradigms had no eﬀects on hippocampal α4 or
δ subunit gene expression during rat adulthood (Centanni
et al., 2014; Van Skike et al., 2015). Furthermore, α4 transcript
levels were not significantly altered in the hippocampal body
of alcoholics or in the total hippocampus of rats genetically
predisposed to EtOH dependence (Enoch et al., 2012).
Overall, these studies provide evidence that excessive EtOH
exposure can have multifaceted eﬀects on hippocampal GABAAR
subunit expression. Nevertheless, diﬀerences in intermittent
exposure/withdrawal durations and consumption methods
(intragastric intubation, injection, liquid diet as sole source of
calories and fluid) lead to distinct patterns of molecular changes
in specific subregions, which do not necessarily account for
vulnerability to EtOH in rodents or contribute to dependence
in alcoholics. In the last decade, better procedures for modeling
alcohol dependence and relapse drinking have been developed
by combining passive EtOH vapor exposure with subsequent
voluntary, free-choice consumption (Becker and Ron, 2014).
In addition, it has been found that the use of inbred mouse
strains results in higher EtOH consumption and blood EtOH
concentrations compared to other rodent models.
Previously, we have shown that both chronic EtOH treatment
in cultured neurons (Follesa et al., 2005) and voluntary two-
bottle choice (2BC) EtOH consumption in mice (Sanna et al.,
2011) increase the abundance of hippocampal GABAAR δ
subunit mRNA and protein. Here, we used repeated cycles of a
Chronic Intermittent EtOH (CIE) exposure in combination with
a 2BC paradigm to examine the relationships between voluntary,
dependence-associated EtOH consumption, its resulting blood
EtOH levels, and GABAAR α4 and δ subunit expressions in
mouse hippocampus. In this paradigm, forced EtOH vapor
exposure is employed to achieve and maintain high blood
EtOH concentrations (BECs) in C57BL/6J mice, and such
exposure results in increased self-administration of EtOH
(Becker and Lopez, 2004). Four repeated bouts of EtOH
exposure and abstinence were used because they result in more
permanent changes in the reinforcing eﬀects of EtOH (Roberts
et al., 2000; Lopez and Becker, 2005). Previous studies using
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this model have suggested that the development of alcohol
dependence and withdrawal involves brain region-specific and
time-dependent profound neuroadaptive alterations in protein
(Gorini et al., 2013; Uys et al., 2015) and gene (Melendez et al.,
2012; Osterndorﬀ-Kahanek et al., 2015) expression, and these
alterations seem to bemore pronounced 8 h after EtOH exposure.
Hence, we measured transcript levels at diﬀerent time points in
the paradigm to better understand how drinking behavior could
aﬀect GABAAR expression. To our knowledge, no study has yet
measured hippocampal GABAAR expression at diﬀerent time
points during and after voluntary EtOH consumption following
forced EtOH vapor exposure in mice by comparing molecular
data with concomitant BECs.
MATERIALS AND METHODS
Subjects
Adult male C57BL/6J mice were bred in our animal facility under
an artificial 12:12 light/dark cycle at a constant temperature of
23◦C, 65% humidity, and ad libitum availability of rodent food
and water. After birth in our animal facility, mouse pups were
left undisturbed with their mothers until weaning (21 days after
birth). At the age of 13 weeks,malemice were selected and housed
in a dedicated room with a diﬀerent 12:12 reverse light/dark
cycle (oﬀ at 10:30 h). In the 14th week, the mice were used
to perform all the procedures listed below. Body weight was
recorded daily while the mice were consuming EtOH and during
CIE exposure cycles. The mice were housed individually when
measuring fluid consumption and regrouped at the end of each
session, and they were not deprived of food or water at any time
during the experiment. This study was carried out in accordance
with the recommendations of the “Guidelines for care and use of
experimental animals” issued by the Italian Ministry of Health
(D.L. 26/2014), by the European Union (2010/63/UE) and the
“Guide for Care and Use of Laboratory Animals”, adopted by
the NIH, USA (8th edition, 2011). The protocol was approved
by the “Committee on Animal Use and Care” of the University of
Cagliari.
General Paradigm Design
The general study design involved the use of an EtOH
dependence and relapse drinking model developed by Dr.
Becker’s laboratory (Becker and Lopez, 2004; Lopez and Becker,
2005; Griﬃn et al., 2009a,b). Briefly, the mice were randomly
divided in two groups, and both groups were first trained to drink
EtOH using a 2BC limited-access procedure (described below)
to stabilize their daily EtOH intake. After this baseline period,
the groups were maintained in inhalation chambers for 4 days
and exposed to EtOH vapor (CIE group) or air. After a 72-h
abstinence period following each inhalation cycle, the CIE and the
air-matched control mice (Air) were tested for 2 h/d 2BC limited-
access EtOH consumption for 7 days. In short, each 4-day CIE/air
exposure cycle was followed by a 7-day limited access drinking
test, and this sequence was repeated four times (Figure 1). Five
separate experiments involving a total of EtOH (n = 63) and
Air (n = 40) mice were conducted for testing voluntary ethanol
consumption over four test cycles of CIE exposure.
Habituation
Using a modified sucrose-fading procedure (SFP; Samson, 1986),
the mice were given daily access to EtOH for 2 h in the home
cage 0.5 h prior to the start of the dark cycle to stabilize their
daily intake. During the 2-h limited access period, the mice were
presented with a 2BC to drink EtOH or tap water, and the
positions of the bottles were alternated on a daily basis. Every day
during the 2-h procedure, the single standard water bottle was
removed from each cage and replaced with two 250 ml bottles,
one containing EtOH/sucrose solutions and the other containing
water/sucrose at matching sucrose concentration during the first
6-day period of the SFP and just water or EtOH thereafter
as follows: 10% EtOH/5% sucrose for 2 days, 12.5% EtOH/4%
sucrose for 2 days, 15% EtOH/2% sucrose for 2 days, and 15%
EtOH/0% sucrose as a final solution for 9 days. At the end of each
2-h access period, the EtOH bottles and the water bottles were
removed, and the one standard water bottle was returned to the
home cage. The EtOH (v/v) solutions were prepared by mixing
95% EtOH with deionized water and adding sucrose (w/v) when
appropriate. All solutions were prepared daily and presented at
FIGURE 1 | Simplified schematic representation of Chronic Intermittent Ethanol (CIE) paradigm combined with voluntary 2BC ethanol (EtOH) intake.
Following habituation [with sucrose-fading procedure (SFP)] and baseline periods, the mice were maintained in inhalation chambers for 4 days and exposed to EtOH
vapor intermittently (CIE group, 4 × 16 h EtOH + 8 h Air) or constant air (Air group). After 72-h of abstinence (WDL) following each inhalation cycle, all mice were
tested for 2 h/d 2BC limited-access EtOH consumption for 7 days. Each 4-day CIE/air exposure cycle was followed by a 7-day limited-access 2BC drinking test,
and this sequence was repeated four times. The last 2BC drinking test lasted 5 days only, leading to a total of 54 days after the end of the baseline period. Samples
were collected twice on day 47 (Sac 1 at 09:30 h, “Post inhalation”, and Sac 2 at 17:30 h, “8 h WDL”), and then on days 50 (Sac 3 at 12:00 h, “72 h WDL + 2BC”)
and 54 (Sac 4 at 12:00 h, “End of paradigm”), as indicated in the section “Materials and Methods.”
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 November 2015 | Volume 9 | Article 445
Follesa et al. GABA(A)R expression during ethanol dependence
room temperature. EtOH intake was measured daily by weighing
the bottles. Diﬀerences with the initial weight were calculated to
establish the amount of EtOH consumed during the 2-h period.
CIE Exposure
Chronic Intermittent EtOH exposure was obtained by using
inhalation chambers as described previously (Becker and Lopez,
2004; Lopez et al., 2012). Briefly, ethanol (95%) was volatilized,
mixed with fresh air, and delivered to the chambers at a rate
of 10 L/min, resulting in vapor concentrations of 15–20 mg/L.
These inhalation conditions have been shown to yield stable BECs
(150–200 mg/dl) during each cycle of intoxication in this mouse
strain (Griﬃn et al., 2009a). The CIE mice were exposed to a 4 -
day cycle of EtOH vapor for 16 h/d (from 17:30 to 09:30 h on
the following day, no exposure for the remaining 8 h). The Air
mice were subjected to the same chamber conditions with air
instead of EtOH vapor. The housing conditions in the inhalation
chambers were identical to those in the colony room. Tomaintain
a high, stable level of intoxication during each cycle of EtOH
vapor exposure (Griﬃn et al., 2009a), the CIE group received
injections of a loading dose of EtOH (1.6 g/kg) and the alcohol
dehydrogenase inhibitor pyrazole (1 mmol/kg, intraperitoneally
in a volume of 0.02 ml/g body weight) before placement into
the EtOH vapor chambers. Similarly, the mice in the Air group
were administered saline and pyrazole before being placed into
the control chambers. All mice received daily pyrazole injections
before their final removal from the chambers.
2BC Limited-access Drinking
After 72 h of abstinence following each inhalation cycle, all mice
were tested for 2 h/d, 2BC limited-access EtOH consumption
for seven consecutive days. As during the SFP, the 2-h daily
drinking sessions included 30 min of light and 1.5-h of darkness
(from 10:00 to 12:00 h). The mice were housed individually for
2 h with access to two drinking bottles, one containing 15% v/v
EtOH and the other containing tap water. The positions of the
bottles was switched daily, and the amount of EtOH consumed
by each mouse was recorded and converted to g/kg based on the
grams of EtOH consumed and body weight. Following the 2 h of
2BC testing, the mice were regrouped. The dependent variables
recorded and analyzed include EtOH intake (gram and gram per
kilogram). Water intake and total fluid intake were measured as
well (data not shown).
Tissue Collection
Samples were collected (in the dark when needed) at four
diﬀerent time points: immediately after the end of the last EtOH
vapor exposure (day 47, 09:30 h; referred as “Post inhalation”) in
the fourth cycle, 8 h after the end of the last EtOH vapor exposure
(day 47, 17:30 h; “8 h WDL”), at the end of the first subsequent
2BC drinking session (day 50, 12:00 h; “72 h WDL + 2BC”), and
at the end of the last 2BC drinking session (day 54, 12:00 h, “End
of paradigm”).
Blood and brain tissues were sampled to measure EtOH
concentrations and GABAAR subunit mRNA levels. Bilateral
hippocampi were dissected, frozen in dry ice, and stored at –80◦C
until they were used for assays, as described below. An amount of
samples suﬃcient to perform a powerful statistical analysis were
collected from a limited number of mice belonging to diﬀerent
experimental groups (as indicated in the figure legends).
Blood Ethanol Assays
Immediately after rapid decapitation, blood samples were
collected from the encephalic trunk using two 70 µL heparinized
capillary tubes per animal, transferred to 1.5 mL tubes containing
10 µL heparin, and mixed for BEC analysis. One hundred
microliters of aliquots in vials were then subjected to gas
chromatography, as described previously (De Martinis and
Martin, 2002; Maeda et al., 2006). Sample concentrations were
determined by interpolating a standard curve; this method
detects concentrations of up to 500 µM EtOH. Briefly, standards
were prepared by diluting ethanol in ACSF and 0.75 M perchloric
acid to mimic sample harvesting. Before the assay, 2 µL of the
obtained standards were aliquoted in vials and heated at 65◦C for
45 min with the samples. Then, 1 mL aliquot from each vial was
injected into the gas chromatography column, and peak heights
were recorded on a chromatogram. Blood ethanol levels were
expressed in units of mg/dl.
Measurement of GABAAR Subunit mRNA
Levels by qRT-PCR
Total RNA was extracted from the frozen hippocampi by
using the guanidine isothiocyanate method (Chomczynski and
Sacchi, 2006) and was quantified by measuring absorbance
at 260 nm. The yield and quality of the isolated RNA was
determined by agarose gel electrophoresis. Single-stranded cDNA
was synthesized from total RNA using the iScriptTM cDNA
Synthesis kit (Bio-Rad, Hercules, CA, USA) according to the
manufacturer’s instructions. The synthesized cDNA was diluted
10 times and used to determine GABAAR subunit mRNA
levels. Following reverse transcription, quantitative RT-PCR
(qRT-PCR) was performed in triplicate using the iQ SYBR
Green Supermix (Bio-Rad) PCR mix containing 100 mM KCl,
40 mM Tris-HCl pH 8.4, 0.4 mM of each dNTP, 50 U/mL
DNA Polymerase (iTaq), 6 mM MgCl2, SYBR Green I, 20 nM
fluorescein, and stabilizers. The reaction was performed using a
thermocycler (Real-Time PCR detection system C1000/CFX96,
Bio-Rad, Hercules, CA, USA) in a final volume of 25 µL (5 µL
RNase-free H2O, 5 µL cDNA template, 2.5 µL of each primer,
and 12.5 µL of 2x iQ SYBRTM Green Supermix) under the
following PCR conditions: initial heating at 95◦C for 3 min
to denature the cDNA and activate the Taq DNA Polymerase,
followed by 40 cycles consisting of denaturation at 95◦C for
30 s, annealing at 60◦C for 60 s, and extension at 72◦C for
2 min. The reaction was then stopped with a final step at
72◦C for 15 min. Qiagen QuantiTect Primer Assay systems with
the following 10X primers were used: GABAAR α4 (product
number 249900, NM_010251, final conc. 1X), and GABAAR δ
(product number 249900, NM_008072, final conc. 1X). Beta-
actin (product number 249900, NM_007393, final conc. 1X),
and GAPDH (product number 249900, NM_008084, final conc.
1X) were used as endogenous control genes. The analysis
was performed using the CFX Manager software (Bio-Rad)
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for calculating gene expression in the analysis mode !!C(t)
according to the manufacturer’s instructions.
Data and Statistical Analysis
The data are presented as mean ± SEM and compared by
one-way or two-way analysis of variance (ANOVA) and an
appropriate test, as indicated in figure legends, by using Prism
software (version 6, GraphPad) or STATISTICA (version 7,
StatSoft Inc.).
Measures of ethanol intake (g/kg/2 h) were averaged over
the 7-day limited access sessions during baseline and each of
the test cycles for each subject. These data were analyzed by
two-way ANOVA, with Group (CIE vs. Air) as a between-
subjects factor and Test Cycle as a repeated measure. For post hoc
multiple comparisons, we used the Newman–Keuls, Bonferroni,
or Dunnett tests, as appropriate, or the t-test and the F test to
compare variances in single-group comparisons, as indicated in
figure legends.
Ethanol concentration in blood samples and GABAAR gene
expression were also analyzed using Student’s t-tests, one or two-
way ANOVA (as appropriate and indicated in figure legends),
followed by the Bonferroni test. Correlation analyses were
conducted using Pearson’s Product Moment analysis. For all
analyses, significance levels were set at p< 0.05.
RESULTS
To determine the eﬀect of forced exposure to EtOH vapor on
2BC voluntary intake, we monitored daily EtOH consumption
(expressed in g/kg/2 h). Daily intake values were averaged over
the 7 days of each 2BC drinking test period. The data obtained
were analyzed to evaluate the 2BC drinking of the CIE vs. the
Air group after each of the four forced exposure cycles. In
agreementwith previous findings (Becker and Lopez, 2004; Lopez
and Becker, 2005), repeated cycles of CIE exposure increased
voluntary EtOH intake in general. Although the baseline intake
was similar for both groups (2.49 ± 0.21 CIE; 2.76 ± 0.19
Air; average 2.63 ± 0.14 g/kg) and drinking in the Air mice
remained relatively unchanged, the average EtOH consumption
was higher in mice subjected to forced EtOH vapor exposure,
reaching ∼4.5 g/kg in the IV cycle (Figure 2A). This was
supported by repeated ANOVA measurements, which revealed a
significant treatment eﬀect (CIE versus Air) [F(1,101) = 48.060,
p = 0.000001], significant cycle eﬀect [F(4,404) = 15.608,
p = 0.000001], and significant treatment × test cycle interaction
[F(4,404)= 3.676, p= 0.00591]. The post hocNewman–Keuls test
revealed that following the first vapor/control chamber exposure,
2BC EtOH consumption in the EtOH vapor-exposed mice (CIE)
increased significantly (+26 ± 4.1%, p < 0.0001) relative to the
control mice (Air) (Figure 2A). This eﬀect was greater after the
second chamber exposure, with post hoc analysis (p < 0.0001)
revealing increased EtOH consumption (+54 ± 4.2%) in CIE
mice relative to Air mice across the second 7-day 2BC limited-
access drinking period. Similar significant increases were evident
even during the third (+49 ± 5%, p < 0.0001) and fourth
(+43 ± 6.3%, p < 0.0001) 2BC test periods. In addition, the post
FIGURE 2 | Effect of repeated cycles of CIE exposure on voluntary 2BC
EtOH intake over time. Forced exposure to EtOH vapor increased average
EtOH consumption in the CIE mice compared to the Air controls. The average
EtOH intake is expressed in g/kg/2 h. The values are mean ± SEM.
(A) Voluntary EtOH consumption was compared between the CIE (full bars)
and the Air (empty bars) mice during baseline and each of the four 2BC
weekly cycles (I, II, III, and IV). Repeated two-way ANOVA measurements
revealed a significant treatment effect [CIE (n = 63) versus Air (n = 40),
F (1,101) = 48.060, p = 0.000001], significant cycle effect [F (4,404) = 15.608,
p = 0.000001], and significant treatment × test cycle interaction
[F (4,404) = 3.676, p = 0.00591]. The post hoc Newman–Keuls test revealed
significant differences (∗∗∗∗p < 0.0001) between each cycle and the baseline
in the CIE but not in the Air mice, whose average consumption was steady
over time. The Bonferroni multiple comparison test showed significant
differences in the amount of EtOH consumed between the Air and the CIE
mice in the corresponding cycle (+++p < 0.001 and ++++p < 0.0001) and a
difference within the CIE group (!p < 0.05) in the amount of EtOH consumed
between cycles I and IV. (B) Voluntary EtOH intake during the first day of each
2BC session in the CIE (full bars) and the Air (empty bars) mice. Two-way
ANOVA revealed a significant treatment effect [CIE (n = 41) versus Air
(n = 35), F (1,68) = 22.11, p = 0.0001], non-significant cycle effect
(Continued)
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FIGURE 2 | Continued
[F (3,68) = 1.001, p = 0.3977], and non-significant treatment × test
cycle interaction [F (3,68) = 0.03780, p = 0.9901]. The Bonferroni multiple
comparison test showed significant differences (∗p < 0.05) between the Air
and the CIE mice in the corresponding cycle. (C) Comparison of average
amount of globally consumed EtOH throughout the week (All week, full and
empty bars) and on each first day (first day, dark and light gray bars) across
all four 2BC tests in the two groups. Two-way ANOVA revealed a significant
treatment effect [F (1,175) = 1010, p < 0.0001], significant first day/all
week effect [F (1,175) = 2593, p < 0.0001], and non-significant interaction
[F (1,175) = 0.5996, p = 0.4398]. The Bonferroni multiple comparison test
showed significant differences (∗∗∗∗p < 0.0001) between the compared
groups. Further, analysis revealed significant effects of the CIE treatments on
both all week [(∗∗∗∗p < 0.0001); t-test: t = 12.04 (101); R2 = 0.5895 and F
test to compare variances F = 1.713 (62,39)] and first day [(∗∗∗p < 0.001);
t-test: t = 3.761 (74); R2 = 0.1606 and F test to compare variances F = 1.416
(40,34)].
hoc analysis revealed a significant increase in EtOH consumption
between cycles I and IV (p< 0.05).
Daily EtOH intake across test periods was also compared
to understand behavioral eﬀects related specifically to the 72-
h withdrawal period following inhalation and before the 2BC
sessions. The average EtOH consumption during the first day of
each 2BC test period was always higher in CIE group compared
to the Air controls (p < 0.05, Figure 2B). This was supported by
the results of repeated ANOVA measurements, which revealed
a significant treatment eﬀect (CIE versus Air) [F(1,68) = 22.11,
p = 0.0001], non-significant cycle eﬀect [F(3,68) = 1.001,
p = 0.3977], and non-significant treatment × test cycle
interaction [F(3,68) = 0.03780, p= 0.9901].
The total amount of EtOH consumed across all four tests
was significantly higher in the CIE mice (+44 ± 2.5%,
p < 0.0001; Figure 2C). The average daily EtOH consumption
was 4.29± 0.07 g/kg/2 h in the CIEmice and 2.99± 0.07 g/kg/2 h
in the Air mice. Moreover, the total amount of EtOH consumed
on the first day across all four tests was significantly higher in the
CIE mice (+33.2 ± 5.49%, p < 0.001) compared to that in the
Air mice (Figure 2C). Furthermore, when comparing only the
first-day global intake against the average weekly consumption,
we found that both the CIE mice and the Air mice consumed
greater amounts of EtOH during the first day (Figure 2C),
with a significant treatment eﬀect [F(1,175) = 1010, p< 0.0001],
significant first day/all week eﬀect [F(1,175)= 2593, p< 0.0001],
and non-significant interaction [F(1,175) = 0.5996, p = 0.4398].
The overall EtOH consumption patterns were consistent with
those observed in similar previous experiments, showing that
repeated exposure to EtOH vapor is associated with subsequent
increases in EtOH consumption under 2BC conditions.
At the very end of our paradigm, immediately before
sample collection (day 54, as denoted by the scheme in
Figure 1), the CIE mice continued to show a small increase
in EtOH intake, although this was not significant (p = 0.1813)
compared to the controls (4.696 and 4.024 g/kg/2 h, respectively;
Figure 3A). Blood ethanol levels were measured in samples
obtained immediately after the final limited access session of
the study (Sac 4 on day 54 in Figure 1); the average BECs of
the two groups were similar (Figure 3B) and not statistically
significant (p = 0.8945). Moreover, as shown in Figure 3C, the
BECs were partially correlated to the average amount of EtOH
consumed during the last-day 2-h access period (R2 = 0.5736;
p < 0.001, and R2 = 0.2913; p < 0.05 for CIE and Air
mice, respectively). Linear regression analysis showed a slope
diﬀerent from zero for the CIE [p = 0.007; F = 18.83 (1,14)]
and the Air groups [p = 0.0309; F = 5.755 (1,14)]. The
analysis also demonstrated no significant diﬀerence between
slopes when comparing the CIE and the Air groups [p = 0.7398;
F = 0.113352 (1,28)], indicating that repeated cycles of EtOH
vapor exposure did not alter EtOH pharmacokinetics in the CIE
mice. Collectively, these results suggest that when EtOH was
presented in a 2BC limited-access paradigm, previous repeated,
forced, chronic EtOH exposures and withdrawal experiences
increased subsequent voluntary intake in the CIE compared
to the Air mice, but this diﬀerence did not seem to last after
prolonged access, at which point the groups showed similar EtOH
intakes and blood levels.
To examine the relationship between voluntary 2BC EtOH
consumption and GABAAR gene expression, we used qRT-PCR
to semi-quantitatively measure the α4 and the δ subunit mRNA
expression levels in the hippocampi of the CIE and the Air group
mice. As shown in Figure 4, the diﬀerences in GABAAR α4 and
δ subunit mRNA levels between the two groups at the end of
the last 2BC drinking session were not statistically significant
(p = 0.4750 and p= 0.2809, respectively).
Furthermore, to better understand the possible contribution
of the withdrawal eﬀect, we compared the α4 and the δ
subunit transcript levels in the CIE mice at three additional,
diﬀerent time points along the paradigm. We found the
highest δ mRNA expression levels at the end of the last
EtOH vapor exposure. These levels decreased significantly
(–25.5 ± 2.3%, p < 0.001) after 8 h of withdrawal from
the inhalation chambers; then, a significant increase
(+19.2 ± 0.4%, p < 0.01) was observed after the first subsequent
2BC drinking session, which was not robust enough to
restore pre-withdrawal expression levels (–14.2 ± 0.3%,
p < 0.01; Figure 4A). Conversely, in the case of the α4
subunit, diﬀerences in the mRNA expression levels at these
three diﬀerent time points were not statistically significant
(Figure 4B).
Finally, to evaluate whether the measured fluctuations in the
GABAAR δ subunit transcript abundance were accompanied by
changes in blood EtOH levels, we compared BECs of the CIE
mice at the same three time points considered above. Remarkably,
we found significant diﬀerences among BECs at these three
diﬀerent time points, with higher EtOH levels immediately
after inhalation, lower (–55 ± 7.4%, p < 0.0001) after 8 h of
withdrawal, and intermediate (–33 ± 3.2%, p < 0.0001) after
the first subsequent 2BC drinking (Figure 5). Accordingly, when
we correlated these changes in BECs with the mRNA expression
levels at the same time points, we found a statistically significant
positive correlation with the δ subunit (R2 = 0.9620; p < 0.0001;
Figure 6A) but no correlation with α4 (Figure 6B), suggesting
that the high BECs reached during forced inhalation, combined
with repeated withdrawal experiences, may induce profound
molecular changes which include the specific eﬀects on GABAAR
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FIGURE 3 | Final effects of CIE exposure on voluntary EtOH intake and
blood EtOH concentrations (BECs) at end of paradigm. EtOH
consumption was measured during the last day (day 54) immediately before
sample collection. EtOH intake is expressed in g/kg/2 h, and BECs are
expressed in mg/dl. The full dots represent the CIE samples, and the empty
dots represent the Air samples. Values are mean ± SEM of 16 CIE and 16 Air
mice. (A) On the last day of the paradigm, EtOH intake levels were similar in
the two groups. A non-significant increase was still evident in the CIE mice
compared to the Air mice [(4.696 and 4.024 g/kg/2 h, respectively);
p = 0.1813; t-test: t = 1.368 (30); R2 = 0.05876 and F test to compare
variances F = 1.422 (15,15)]. (B) Blood EtOH levels were measured
immediately after sample collection (Sac 4). The differences between the
average BECs of the two groups were not statistically different [p = 0.8945;
t-test: t = 0.1337 (30); R2 = 0.0005955 and F test to compare variances
F = 1.023 (15,15)]. (C) Correlation between the amount of EtOH intake by the
CIE and the Air groups during the final session of the last 2BC test and the
resultant BECs measured immediately after the drinking session. Pearson
correlation analysis of the data showed R2 = 0.5736 for the CIE group and
R2 = 0.2913 for the Air group (p = 0.0007 and p = 0.0309, respectively).
Linear regression analysis showed a slope different from zero for the CIE
group [p = 0.007; F = 18.83 (1,14)] and the Air group [p = 0.0309; F = 5.755
(1,14)]. The analysis also demonstrated no significant difference between
slopes when comparing the two groups [p = 0.7398; F = 0.113352 (1,28)].
FIGURE 4 | Effects of repeated cycles of CIE paradigm on
hippocampal GABAAR subunit mRNA expression at different time
points. Semi-quantitative data were obtained by qRT-PCR and gene fold
expression levels were normalized against housekeeping mRNA. The first
three bars in both graphs refer to the CIE mice immediately after the last
forced exposure to EtOH vapor (Post inhalation), 8 h after the last exposure to
EtOH vapor (8 h WDL), and right after the first subsequent 2BC drinking
session (72 h WDL + 2BC). GABAAR mRNA expression levels are shown for
the δ (A) and the α4 (B) subunits. Only the δ mRNA expression data showed
statistical significance, as indicated. The last two bars in both graphs refer to
fold expression in the CIE and the Air mice at the end of the paradigm,
immediately after the last 2BC session in the last test week. At this stage, no
statistical differences were observed between CIE (n = 10) and Air (n = 9) for
both the δ [p = 0.2809; t-test: t = 1.114 (17); R2 = 0.06801 and F test to
compare variances F = 2.458 (9,8)] and the α4 [p = 0.4750; t-test:
t = 0.7305 (17); R2 = 0.03043 and F test to compare variances F = 1.076
(9,8)] subunit mRNA levels. Multiple comparison ANOVA of the first three time
points showed significance between treatments with p < 0.0001, F = 46,41
(2,13), followed by the Bonferroni multiple comparison post hoc test,
∗∗p < 0.01; ∗∗∗p < 0.001. The values are means ± SEM in triplicates of 4, 8,
and 4 mice for post inhalation, 8 h WDL, and 72 h WDL + 2BC, respectively.
gene expression that were not more evident after subsequent
voluntary EtOH intake.
DISCUSSION
Adeeper understanding of the molecular adaptation mechanisms
occurring after prolonged excessive EtOH consumption,
including behavioral, neurochemical, and functional, is essential
for developing novel therapeutic approaches to treat alcohol
use disorders. Several models of excessive EtOH consumption
have been established to explore the progression that leads to
dependence, including Chronic Intermittent EtOH exposure,
with (Becker and Lopez, 2004; Finn et al., 2007; Griﬃn et al.,
2009a,b; Gorini et al., 2013) or without (Melendez et al., 2012;
Maldonado-Devincci et al., 2014; Osterndorﬀ-Kahanek et al.,
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FIGURE 5 | Effects of repeated cycles of CIE paradigm on plasmatic
EtOH levels across different time points. BECs were measured
immediately after samples collection. BECs are expressed in mg/dl. The first
three bars refer to the CIE mice immediately after the last forced exposure to
EtOH vapor (Post inhalation), 8 h after the last exposure to EtOH vapor (8 h
WDL), and right after the first subsequent 2BC drinking session (72 h
WDL + 2BC). Statistical differences among BECs at these three different time
points are indicated. The two bars on the right refer to BECs in the CIE and
the Air mice at the end of the paradigm, immediately after the last 2BC
session in the last test week. At this stage, the difference between the
average BECs of the two groups was not statistically significant [CIE (n = 15)
and Air (n = 15); p = 0.8945; t-test: t = 0.1337 (30); R2 = 0.0005955 and F
test to compare variances F = 1.023 (15,15)]. Multiple comparison ANOVA of
the first three time points showed significance between treatments with
p < 0.0001, F = 34.60 (2,18), followed by the Bonferroni multiple comparison
post hoc test, ∗∗∗∗p < 0.0001 vs. Post inhalation; !p < 0.05 between 8 h
WDL and 72 h WDL + 2BC. The values are means ± SEM of 6, 6, and 9 mice
for post inhalation, 8 h WDL, and 72 h WDL + 2BC, respectively.
2015; Staples et al., 2015; Uys et al., 2015) combined 2BC
voluntary consumption.
In our study, C57BL/6J mice were initially allowed to
self-administer EtOH until the positive reinforcing eﬀects of
EtOH were established. Then, the mice were subjected to
four cycles of forced exposure to EtOH vapor, followed by
EtOH withdrawal, and separated by weekly tests of 2BC
voluntary intake. This model is intended to mimic human EtOH
consumption, where periods of high intake are followed by
abstinence owing to medical aid or treatment, and possibly
subsequent relapse.
The escalation of voluntary EtOH drinking previously
observed over several successive cycles of CIE exposure (Lopez
and Becker, 2005; Lopez et al., 2012) was confirmed in our
experiments (Figure 2A). While the intensity and duration of
EtOH exposure play a major role in contributing to the escalation
of drinking in dependent animals (Griﬃn et al., 2009a), the
biological mechanisms driving such escalation remain unclear
and all minor variations in the paradigm can potentially influence
intake levels.
As reported previously (Becker and Lopez, 2004; Lopez and
Becker, 2005), our results show that mice exposed to Chronic
Intermittent EtOH vapor inhalation consumed higher volumes of
EtOH compared to the controls (Figures 2A,C) when subjected
to a free-choice paradigm. The increased EtOH consumption is
FIGURE 6 | Correlation between hippocampal GABAAR subunit mRNA
expression and concomitant plasma EtOH levels measured at different
time points in CIE paradigm. Correlations were calculated for the GABAAR
δ (A) and the α4 (B) subunit levels. Data corresponding to the first three time
points shown in Figures 4 and 5 (Post inhalation, 8 h WDL, and 72 h
WDL + 2BC) were analyzed. BECs are expressed in mg/dl. GABAAR subunit
mRNA expression semi-quantitative levels were obtained by qRT-PCR, and
gene fold expression levels were normalized with housekeeping mRNA.
Pearson’s Product Moment analysis showed a significant correlation for the δ
subunit (R2 = 0.9620; p < 0.0001) but not for the α4 (R2 = 0.1635;
p = 0.1516). Linear regression analysis showed a slope different from zero for
the δ subunit [p < 0.0001; F = 303.4 (1,12)] but not for the α4 subunit
[p = 0.1516; F = 2.345 (1,12)].
not due to the need to hydrate because the animals were not
deprived of water at any time during the experiment. This higher
intake level accompanied by a compulsive drinking habit could
be explained by an altered physiological state associated with
tolerance and dependence. In the CIE animals, such behavior
produces cerebral and plasmatic EtOH concentrations similar
to those reached during prior forced exposure in inhalation
chambers (Griﬃn et al., 2009b) and was thus likely to re-establish
a similar intoxication experience along with the related positive
reinforcement properties. Our data show consistently that blood
EtOH levels after the first 2BC session following withdrawal were
markedly higher compared to those measured at the end of the
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paradigm (Figure 5), although they were lower than those during
vapor exposure.
At the end of the 72-h abstinence period following withdrawal
from EtOH vapor, the CIE mice exhibited a faster rate of EtOH
intake compared to the controls (Griﬃn et al., 2009b). Thus, as
they developed compulsive and anxious behavior leading them
to rapidly consume greater amounts of EtOH, they escaped from
unpleasant withdrawal symptoms or at least partially cleansed
the negative eﬀects of withdrawal (Becker, 2000; Heilig et al.,
2010). Indeed,multiple studies suggest that CIE exposure induces
a hyperglutamatergic state in the nucleus accumbens (Griﬃn
et al., 2014), where changes in the dendritic spine morphology
(Uys et al., 2015) could contribute to the augmented rewarding
eﬀects of EtOH observed after self-administration in diﬀerent
rodent models (Roberts et al., 2000; O’Dell et al., 2004; Gilpin
et al., 2008; Lopez and Becker, 2014; Vendruscolo and Roberts,
2014). As described in our results, the CIE and the Air mice
showed higher EtOH consumption during the first day of the
2BC sessions following the withdrawal periods, with the CIEmice
consuming a greater amount of EtOH compared to the Air group
(Figures 2B,C). Such an eﬀect was not as evident in previous
reports (Becker and Lopez, 2004; Finn et al., 2007; Gorini et al.,
2013), where CIE mice tended to drink less EtOH during the
first 2BC day in comparison with the subsequent days. The fact
that the Air and the CIE mice showed a similar pattern of initial
consumption suggests that their drinking behavior is driven in
part by the consequences of withdrawal, which was longer in the
Air group.
Although the amounts of EtOH consumed on the first day
of 2BC were higher in the CIE compared to the Air mice
(Figure 2B), they were also higher than the 7-day average values
for CIE mice (Figure 2C). When analyzing daily intake during
the last 2BC test, we found that despite the substantial gap in
EtOH intake in the CIE mice vis-à-vis the Air mice on the first
day, the two groups ended up with more comparable EtOH
consumption levels (Figure 3A) and similar BECs (Figure 3B)
on the very last day of the paradigm, indicating that repeated
cycles of intermittent EtOH vapor exposure did not alter EtOH
pharmacokinetics in CIE mice, which corroborates the results of
previous studies (Becker, 1999; Lopez et al., 2012).
Collectively, behavioral data suggest that persistent cycles
of forced exposure to EtOH followed by withdrawal and
voluntary intake are likely associated with gaining relief from
withdrawal symptoms, greater rewarding eﬀects, and tolerance,
which all promote andmaintain excessive dependence-associated
consumption. Nevertheless, complex molecular dynamics might
contribute to these behavioral responses. Therefore, a major goal
of our study was to evaluate the molecular changes underlying
the adaptation of the hippocampal GABAergic system to Chronic
Intermittent EtOH vapor exposure combined with 2BC voluntary
intake.
We have previously shown that chronic EtOH exposure can
aﬀect the GABAAR gene expression of hippocampal neurons in
culture (Follesa et al., 2005) and in mice (Sanna et al., 2011). Here,
we focused on the α4 and the δ subunit mRNA expressions, which
are sensitive to acute EtOH modulation (Sundstrom-Poromaa
et al., 2002; Wallner et al., 2003; Wei et al., 2004), following a CIE
exposure paradigm. In agreement with consumption data, we did
not find significant changes in the α4 and the δ subunit transcript
levels between groups at the end of the paradigm (Figure 4). This
might suggest that putative perturbations in the α4 and the δ
levels could have been transient in the CIE mice and related to
the diﬀerences in EtOH consumption between the groups, which
were less pronounced at that stage.
Surprisingly, we did not find significant changes in the
α4 subunit mRNA expression when we compared normalized
transcript levels at three additional time points across the
paradigm (Figure 4B), although it had been shown previously
that this GABAAR subunit undergoes rapid fluctuations during
EtOH withdrawal in cell cultures (Follesa et al., 2003, 2005) and
that its overexpression is associated with long-term dependence
in alcoholics (Jin et al., 2012), greater anxiety in animal
models (Smith et al., 1998b; Cagetti et al., 2003), and reduced
neurosteroid levels during social isolation (Serra et al., 2006)
or after delivery (Sanna et al., 2009). Our group has previously
reported that social isolation induced increased hippocampal α4
and δ subunit gene expression in C57BL/6J mice and that stress-
induced EtOH 2BC self-administration can prevent changes in
α4 but not in the δ subunit (Sanna et al., 2011). Conversely,
in the present study it is possible that we might not have
been able to detect similar variations in α4 gene expression
owing to potentially altered responses to stress in the CIE
dependent animals (Kumar et al., 2009; Heilig et al., 2010;
Mody and Maguire, 2011), concurrent modifications of other
GABAAR subunits that can be assembled with δ (Glykys et al.,
2007; Suryanarayanan et al., 2011), transport of α4-containing
GABAARs from extrasynaptic to synaptic locations following
EtOH exposure (Liang et al., 2006), and long-lasting changes
in hippocampal structural plasticity (i.e., dendritic arborization)
induced by CIE exposure (Staples et al., 2015).
Remarkably, when we compared hippocampal δ subunit
mRNA expression at diﬀerent time points in the CIE mice,
we found an initial upregulation after EtOH vapor exposure,
followed by a sudden downregulation 8 h after their removal
from the inhalation chambers (Figure 4A). This decrease suggests
a molecular adaptation in the hippocampal GABAergic system
to partially recover the neuronal excitability compromised by
EtOH intoxication, eventually leading to increased excitability
with higher avidity for EtOH, which is typical of withdrawal
conditions. After the subsequent first day of 2BC voluntary
drinking, a significant net upregulation in δ mRNA levels
partially recovered the subunit expression, but failed to
restore pre-withdrawal transcript levels (Figure 4A). Our
group has previously reported δ subunit upregulation in the
hippocampi of C57BL/6J mice subjected to voluntary EtOH
consumption (Sanna et al., 2011). Thus, δ upregulation observed
after 2BC EtOH consumption following abstinence could re-
establish neuronal excitability to partially overcome the opposite
regulation observed during withdrawal.
Moreover, when we compared BECs in the CIE mice at
the same three time points, we found significant diﬀerences,
which were parallel to the observed fluctuations in GABAAR
δ subunit transcript abundance (Figure 5). This supports the
view that reduced blood and, thus, brain EtOH concentrations
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during EtOH withdrawal induce molecular neuroadaptations in
hippocampal GABAergic transmission. These changes might,
in turn, possibly contribute to an increase in the intake of
and avidity for EtOH when it is presented again for voluntary
drinking. Additionally, fluctuations in the δ subunit might
partly depend on exposure/consumption because they were
directly correlated to the resulting BECs, at least in the three
stages examined (Figure 6A), resembling the molecular and
functional changes observed in cultured hippocampal neurons
by varying EtOH concentration (Follesa et al., 2005). Thus, a
general increase in δ-containing hippocampal GABAARs might
represent a physiological response to high EtOH concentrations
during forced exposure to EtOH vapor, as well as after self-
administration. However, the interpretation of its biological
significance is complicated by the fact that the technique used did
not allow for discrimination among the diﬀerent hippocampal
subregions, cellular subpopulations, and GABAARs localization.
Nevertheless, the reported changes in the expression levels of
δ-containing GABAARs, associated with corresponding shifts in
the hippocampal GABAergic tonic current (Sanna et al., 2011),
involve alterations in the physiological response to stress and
anxiety (Sarkar et al., 2011;Whissell et al., 2015), which ultimately
change the sensitivity of mice, sustaining addictive behavior
(Heilig et al., 2010).
In the present study, the transient withdrawal-induced
decrease in δ subunit mRNA levels, observed 8 h after the fourth
EtOH vapor cycle, might be accompanied by an internalization
of δ-containing GABAARs and a complementary increase of
γ-containing receptors, which are less sensitive to EtOH and are
able to mediate synaptic currents. These transient adaptations
might recur with each 72-h abstinence cycle and entail more
severe, long-lasting changes in hippocampal cellular morphology
(Staples et al., 2015) and in the plasticity of reward neurocircuitry
(Uys et al., 2015), which could contribute to relapse vulnerability
and escalate intake levels over time. Therefore, it would be
interesting to monitor BECs and complementary molecular
changes in additional subunits during each withdrawal cycle, test
direct causality for such complex drinking-related regulation of
GABAAR subtype expression, and include earlier time points to
better cover the temporal evolution of the observed changes.
Our study provides new evidence pertaining to the
dynamic regulation of the GABAAR δ subunit during alcohol
dependence, contributes to the understanding of its role in
other addictive and comorbid conditions, and suggests possible
behavioral implications, which may be important for individual
responsiveness to therapeutic drugs.
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